Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CytomX Therapeutics (CTMX) Tax Provisions: 2015-2025

Historic Tax Provisions for CytomX Therapeutics (CTMX) over the last 5 years, with Sep 2025 value amounting to $58,000.

  • CytomX Therapeutics' Tax Provisions fell 4.92% to $58,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $245,000, marking a year-over-year decrease of 80.08%. This contributed to the annual value of $224,000 for FY2024, which is 94.24% down from last year.
  • CytomX Therapeutics' Tax Provisions amounted to $58,000 in Q3 2025, which was down 7.94% from $63,000 recorded in Q2 2025.
  • CytomX Therapeutics' 5-year Tax Provisions high stood at $2.8 million for Q3 2023, and its period low was $49,000 during Q1 2024.
  • Moreover, its 3-year median value for Tax Provisions was $62,000 (2025), whereas its average is $477,556.
  • Per our database at Business Quant, CytomX Therapeutics' Tax Provisions slumped by 97.84% in 2024 and then climbed by 26.53% in 2025.
  • Over the past 3 years, CytomX Therapeutics' Tax Provisions (Quarterly) stood at $1.1 million in 2023, then slumped by 94.20% to $62,000 in 2024, then decreased by 4.92% to $58,000 in 2025.
  • Its Tax Provisions stands at $58,000 for Q3 2025, versus $63,000 for Q2 2025 and $62,000 for Q1 2025.